Viyash Scientific Reports Strong Q1 FY27 Results, Driven by Growth and Integration Efforts
Hyderabad: Viyash Scientific Limited (formerly SeQuent Scientific Limited) announced its unaudited financial results for the quarter ended June 30, 2026. The company, which operates across Formulations, APIs, and CDMO Services for both Human and Animal health, reported robust growth in Q1 FY27, reflecting successful integration efforts and improved operational leverage.The company's standalone performance showed significant gains. Revenues reached ₹ 9,464 Million, marking a 19.5% increase. EBITDA stood at ₹ 2,047 Million, which saw a substantial rise of 59.2%. Furthermore, Profit After Tax (PAT) was reported at ₹ 793 Million, representing an...